Anemia and mortality in patients with nondialysis-dependent chronic kidney disease

BACKGROUND: A combination of safety concerns and labeling changes impacted use of erythropoiesis-stimulating agents (ESAs) in renal anemia. Data regarding contemporary utilization in pre-dialysis chronic kidney disease (CKD) are lacking. METHODS: Electronic healthcare records and medical claims data...

Descripción completa

Detalles Bibliográficos
Autores principales: Stirnadel-Farrant, Heide A., Luo, Jiacong, Kler, Lata, Cizman, Borut, Jones, Delyth, Brunelli, Steven M., Cobitz, Alexander R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5996482/
https://www.ncbi.nlm.nih.gov/pubmed/29890958
http://dx.doi.org/10.1186/s12882-018-0925-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5996482/
https://www.ncbi.nlm.nih.gov/pubmed/29890958
http://dx.doi.org/10.1186/s12882-018-0925-2

Ejemplares similares